DAFNA Capital Management’s Aptose Biosciences APTO Stock Holding History
Bought
Maintained
Sold
Other funds holding APTO
BBA
KCM
DAFNA Capital Management's APTO Position: Q4 2015 in Review
DAFNA Capital Management sold out of Aptose Biosciences (APTO) in Q4 2015, closing a stake of 43 shares — an estimated $83K sold.
DAFNA Capital Management first reported a position in APTO in Q1 2015 and held it in 3 quarters. The position peaked at $359K in Q2 2015. 11 funds tracked by Wall St. Rank hold APTO as of Q4 2015.
- DAFNA Capital Management reported no remaining Aptose Biosciences position as of Q4 2015 after selling out during the quarter.
- DAFNA Capital Management sold 43 Aptose Biosciences shares in Q4 2015, an estimated $83K.
- DAFNA Capital Management first reported a position in Aptose Biosciences in Q1 2015 and held it in 3 quarters.
- DAFNA Capital Management's Aptose Biosciences position peaked at $359K in Q2 2015.
- 11 funds tracked by Wall St. Rank held Aptose Biosciences as of Q4 2015.
Based on DAFNA Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.